Nephrology
News, opinions and meeting coverage in nephrology.
— How GLP-1 drugs are reshaping medicine
Latest in Nephrology
Previously, such transplants could be done only as part of research studies
In WeightWatchers study, 45% decreased their alcohol use after initiating a weight-loss drug
But how to achieve equitable use remains "complicated," says expert
But how to achieve equitable use remains "complicated," says expert
Nephrology Case Studies
Consider metastatic or ectopic calcification in diagnosing unexplained symptoms in ESRD patients
Surgery had beneficial role
Lab tests, physical exam not helpful -- but history-taking offers a clue
More in Nephrology
Standard of care prevails in single-center trial
More patients taking sodium zirconium cyclosilicate achieved normokalemia vs placebo recipients
Benefit shown in trial of patients flagged for high risk of cardiotoxicity
Intranasal bumetanide demonstrated safety, bioequivalence with its oral and IV counterparts
Most are eligible for weight management indication
Accuracy above 85% in early testing -- far better than proteinuria and biopsy
One-time treatment with nexiguran ziclumeran tied to decline in serum TTR levels in phase I trial
SUMMIT trial able to show clinical benefit beyond quality-of-life improvement
BPROAD trial replicates SPRINT trial findings in diabetes population in China
Also in TTHealthWatch: frailty as a predictor of dementia
Real-world data suggested semaglutide, liraglutide reduced AUD-related hospitalizations
Plus: oral semaglutide outcomes and incident hypertension in teens on GLP-1 drugs
Researchers try to address challenge of distinguishing HCM from other cardiomyopathies
